» Articles » PMID: 25328546

Diabetes Effects on Dental Implant Survival

Overview
Journal Forum Implantol
Date 2014 Oct 21
PMID 25328546
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this review is to critically appraise the clinical evidence guiding our application of dental implant therapy relative to glycemic control for patients with diabetes. Our initial searches of the literature identified 129 publications relevant to both dental implants and diabetes. These were reduced to 17 clinical studies for inclusion. Reported implant failure rates in these 17 reports ranged from 0 to 14.3% for patients with diabetes. Unfortunately, the majority of these reports lacked sufficient information relative to glycemic control to allow the application of the findings toward clinical care. However, clinical evidence is emerging from several investigations that diabetes and glycemic control are important considerations that may require modifications to therapeutic protocols, but may not be contraindications to implant therapy in diabetes patients. Also, a potentially important role for implant therapy to support oral function in diabetes dietary management remains to be determined.

Citing Articles

Success Rates of Dental Implants in Patients With Diabetes: A Systematic Review.

James Y, Butt W, Shahid H, Ahmad S, Imran M, Anthony N Cureus. 2025; 16(12):e76361.

PMID: 39867008 PMC: 11759002. DOI: 10.7759/cureus.76361.


A Comparative Study Evaluating Implant Success and Bone Loss in Diabetes and Nondiabetes.

Sultana R, Raj A, Barbi W, Afridi S, Mishra B, Malik R J Pharm Bioallied Sci. 2022; 13(Suppl 2):S1410-S1413.

PMID: 35018000 PMC: 8686948. DOI: 10.4103/jpbs.jpbs_229_21.


Dental Implant Survival and Complication Rate over 2 Years for Individuals with Poorly Controlled Type 2 Diabetes Mellitus.

Eskow C, Oates T Clin Implant Dent Relat Res. 2016; 19(3):423-431.

PMID: 27990756 PMC: 5453839. DOI: 10.1111/cid.12465.

References
1.
Shernoff A, Colwell J, Bingham S . Implants for type II diabetic patients: interim report. VA Implants in Diabetes Study Group. Implant Dent. 1994; 3(3):183-5. DOI: 10.1097/00008505-199409000-00009. View

2.
Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

3.
Cohen A, Horton E . Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control. Curr Med Res Opin. 2007; 23(4):905-17. DOI: 10.1185/030079907x182068. View

4.
Moy P, Medina D, Shetty V, Aghaloo T . Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants. 2005; 20(4):569-77. View

5.
. Consensus report. Implant therapy II. Ann Periodontol. 1996; 1(1):816-20. DOI: 10.1902/annals.1996.1.1.816. View